Seoul, South Korea

Koun Ho Lee

This inventor holds 1 USPTO granted patent. Top assignees: Cj Corporation, Jeil Pharm. Co., Ltd., Korea Research Institute of Bioscience and Biotechnology. Active years: 2010.


Average Co-Inventor Count = 19.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Koun Ho Lee

Introduction

Koun Ho Lee is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of chemical technology, particularly through his innovative patents. His work focuses on developing compounds that can have a positive impact on health and wellness.

Latest Patents

Koun Ho Lee holds a patent for "Indene derivatives and process for the preparation thereof." This inventive patent describes indene derivatives capable of selectively modulating the activities of peroxisome proliferator-activated receptors (PPARs). These derivatives are beneficial for treating and preventing various disorders, including metabolic syndromes such as diabetes, obesity, and hypertension, as well as inflammatory diseases and cancer.

Career Highlights

Throughout his career, Koun Ho Lee has worked with prominent organizations, including the Korea Research Institute of Chemical Technology and Jeil Pharm Co., Ltd. His experience in these institutions has allowed him to develop his innovative ideas and contribute to advancements in chemical technology.

Collaborations

Koun Ho Lee has collaborated with several talented individuals in his field, including Hyae Gyeong Cheon and Sung-eun Yoo. These collaborations have further enriched his research and development efforts.

Conclusion

Koun Ho Lee's contributions to the field of chemical technology through his innovative patents demonstrate his commitment to improving health outcomes. His work continues to influence the treatment of various medical conditions, showcasing the importance of innovation in science and technology.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…